Open AccessNEW STRATEGY FOR DRUG TREATMENT OF LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER
Author(s) -
Е. В. Артамонова
Publication year - 2017
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2017-6-30-37
Subject(s) - palbociclib , metastatic breast cancer , tolerability , medicine , cyclin dependent kinase , letrozole , breast cancer , oncology , cancer , disease , adverse effect , cell cycle , aromatase